Education Courses

Saturday, April 27, 2019
Print

Education Courses

Separate registration is required for all Education Courses. Preliminary information about each course is listed below for your reference. 

Full-day courses 

Artificial intelligence – from benchtop to bedside

8am – 4:30pm

Lead Organizer: Michael David Abramoff, MD, PhD, FARVO, Ophthalmology & Visual Sciences, University of Iowa Hospitals & Clinics, IDx 

Co-organizers: Rajat N Agrawal, MD, MS, CEO Retinal Global, Michael F Chiang, MD, Ophthalmology and Medical Informatics, Oregon Health & Science University, Susan C Orr, OD, Chief Medical Officer & VP Medical Affairs, Notal Vision, Arthur H Shedden, Jr., MBA, MD, Senior Safety Officer, Johnson & Johnson Vision Care, Inc., Daniel SW Ting, MD, PhD, Singapore National Eye Centre and Tien Y Wong, FRCS, PhD, FARVO, Singapore National Eye Centre.

Artificial Intelligence, (AI) including  machine learning,  is the latest innovation in information technology. The use of AI for improving healthcare outcomes already shows promise. This course will help participants define what AI is, describe applications of AI in research/development, explain the tools behind AI, and explore the future of AI. This activity's overall purpose is to ensure change in learner competence by providing an overview, explaining the principles of use, demonstrating examples of applications, exploring future directions and considering ethical principles. Panel discussions will enable discussion of these topics between the audience and presenters.

For those who are interested to embark on the AI research journey, this course serves as an excellent platform for the audience to learn from the basics. For those who are more familiar with the subjects, this course offers the opportunity to discuss what is the best way forward to use this ground-breaking technology in the lab and in the clinic. For those who are interested in simply understanding the growing impact of AI on clinical practice and on the world in general, this course will provide a comprehensive overview of the field.

After attending this Education Course, the participant will be able to:

  • Define AI and related methodologies
  • Describe the underlying principles of AI
  • State examples of application of AI in research and medical technology
  • Summarize challenges associated with AI
  • Discuss the potential future of AI

View the preliminary agenda


Diabetic retinopathy: What’s new

8am – 4:30pm

Organizers: Renu A Kowluru, PhD FARVO, Wayne State Univeristy, Kresge Eye Institute, (Lead) and Arup Das, MD, PhD, University of New Mexico School of Medicine, NM VA Health Care System

The global prevalence of diabetes mellitus is predicted to increase dramatically in the coming decades from an estimated 382 million in 2013 to 592 million by 2035. Type 2 diabetes (T2D) has already attained epidemic levels with type 1 (T1D) increasing. Diabetic retinopathy (DR) is the most common microvascular complication of diabetes. As such, DR-related visual impairment and blindness has significantly increased. Additional therapeutic options are needed along with approaches to preventative and regenerative medicine that could provide the means to better manage DR. This course will give an update on the molecular mechanisms and clinical management of DR and future therapies in the pipeline in order to increase the clinical knowledge, competence, and performance of learners.

After attending this Education Course, the participant will be able to:

  • Recognize the molecular mechanisms of diabetic retinopathy and experimental models
  • Describe the role of microbiome and diagnostic studies in DR
  • Review the systemic factors and genetics, and major clinical trials
  • Manage DR patients based on an approach combining control of systemic factors, laser therapy, pharmacotherapy (anti-VEGF and steroids), and surgical therapies
  • Communicate updates related to novel therapies and drugs in the pipeline

View the final agenda

ARVO designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The AMA has determined that physicians not licensed in the USA who participate in this CME activity are eligible for AMA PRA Category 1 Credits™.

View the CME program information


Applying electrophysiological techniques to translational vision research

8:30am – 4:30pm

Organizer: Mitchell G Brigell, PhD FARVO, VP Clinical Development, Aerpio Pharmaceuticals

With the advent of new therapies for blinding diseases involving the retina and optic nerve, there is an increasing need for functional outcome measurements that can be made in animal models and human clinical trials. The electroretinogram and visual evoked potential are translatable techniques that fit this purpose. This course will discuss the use of the electrophysiologic techniques in the understanding of retinal dystrophies, acquired retinal diseases, glaucoma and optic nerve diseases. It will include discussions about cellular origins, animal models and clinical research applications. Attendees will leave the course with a better understanding of how to use electrophysiological techniques in their research to characterize the effects of disease and therapeutic intervention on the visual pathways.

The content of this course is suitable for basic and clinician scientists who are new to the use of electrophysiological techniques.

After attending this educational course, the participant will be able to:

  • Incorporate electrophysiological measures into their research
  • Discuss the cellular origins of the responses and their relation to structural and other functional measures of retinal and optic nerve function
  • Incorporate international standards for recording and interpreting electrophysiologic signals into translational and clinical research

View the final agenda


Half-day courses

Ocular immunology: Fundamentals, disease entities, and future therapeutic opportunities

8am – 12pm

Organizers: Reza Dana, MD, Mass. Eye & Ear Infirmary / Harvard Medical School, (Lead), Sunil Chauhan, PhD, Harvard Medical School and Daniel Saban, PhD, Duke University School of Medicine

This education course will introduce the principles of immunology and immunological privilege at is pertains to eye physiology and disease.  Key aspects covered in this course include cellular and molecular factors that maintain immune homeostasis in different ocular compartments, and how breakdown of these pathways gives rise to disease etiologies, such as infection, allergy, alloimmunity, autoimmunity, and aging.  Basics of immune modulation and immune-based targeted therapies will also be discussed.  This course will give an update on current areas of research and future opportunities for targeted immune-based therapies to increase the clinical knowledge, competence, and performance of learners.

The content of this course is suitable for basic and clinician scientists new to the study of ocular immunology.

After attending this educational course, the participant will be able to:

  • Describe the components of the immune system and immunologic privilege as it pertains to the eye.
  • Recognize key cellular and molecular factors driving pathology in ocular immune/inflammatory conditions.
  • Evaluate current areas of research on immune modulation and future opportunities for targeted immune-based therapies.

View the final agenda

ARVO designates this live activity for a maximum of 3.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The AMA has determined that physicians not licensed in the USA who participate in this CME activity are eligible for AMA PRA Category 1 Credits™.

View the CME program information


Statistical methods for correlated eye data

8am – 12pm

Organizers: Maureen G Maguire, PhD, FARVO, University of Pennsylvania and Gui-shuang Ying, PhD, University of Pennsylvania

In this educational course, diverse sets of statistical methods for correlated eye data will be presented and explored.  Selected research study designs that require the use of these statistical methods will be reviewed to evaluate the underlying models and accompanying assumptions and contrast the implications of having the two eyes in different comparison groups versus having both eyes in the same group. Methods for continuous and binary data, with and without covariates, and for cross-sectional and longitudinal study designs will be applied to different datasets and the interpretation of results discussed. Code to implement each example in SAS, Stata, and R statistical software will be provided in course handouts.  The goal of this course is to improve learner competence and performance regarding statistical methods for correlated eye data.

Clinical and basic researchers who need to analyze data from both eyes of study subjects or animals will benefit from taking this advanced level course. Prerequisite: Attendees should be familiar with basic statistical analysis techniques, including linear and logistic regression analysis.

After attending this course, participants will be able to:

  • Recognize research study designs that require statistical methods for correlated eye data.
  • Evaluate comparisons of groups when the two eyes of an individual are in different or the same groups using simple methods that do not accommodate covariates and more complex model-based methods that do accommodate covariates.
  • Explain the results of statistical analyses for correlated eye data.

View the final agenda

ARVO designates this live activity for a maximum of 3.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The AMA has determined that physicians not licensed in the USA who participate in this CME activity are eligible for AMA PRA Category 1 Credits™.

View the CME program information

Accreditation statement

The Association for Research in Vision and Ophthalmology (ARVO) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.